ENTITY
Samsung Biologics

Samsung Biologics (207940 KS)

435
Analysis
Health CareSouth Korea
Samsung Biologics Co.,Ltd. manufactures bio-healthcare products. The Company develops, refines, and distributes biopharmaceutical products.
more
27 Nov 2025 07:02

KOSPI Size Indices: Lots of Change as Averaging Starts

There could be 34 migrations for the KOSPI Size Indices in March. Among new listings, there could be 1 LargeCap add, 2 MidCap adds and 2 SmallCap...

Logo
625 Views
Share
bullishIsupetasys
18 Nov 2025 17:34

KOSPI200 Index Rebalance: Nearly Perfect

As expected, there are 7 changes a side (ignoring the merger, which was known). No ad hoc inclusions since the Hyundai merger offsets the Samsung...

Logo
451 Views
Share
10 Nov 2025 07:05

KRX Foreign Holding Weekly (Nov 7th): SK Hynix, Doosan Enerbility, NAVER, Hanwha Ocean, SKSQUARE

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in SK Hynix, Doosan Enerbility, NAVER, Hanwha Ocean,...

Logo
191 Views
Share
bullishAlteogen Inc
06 Nov 2025 14:10

Alteogen: 2nd Largest Shareholder Raises Stake & Requests Switching Listing from KOSDAQ to KOSPI

Alteogen announced that it will hold an EGM on 8 December to vote on a transfer of listing to KOSPI from KOSDAQ. On 7 July, the second largest...

Logo
508 Views
Share
03 Nov 2025 07:05

KRX Foreign Holding Weekly (Oct 31st): SK Hynix, Samsung Electronics, Hanwha Ocean, Hyundai Motor

We analyzed KRX foreign holding data for the past week and highlighted foreign holding changes in SK Hynix, Samsung Electronics, Hanwha Ocean,...

Logo
473 Views
Share
x